Celldex Therapeutics Ownership 2024 | Who Owns Celldex Therapeutics Now?
Institutional Ownership
10.54%
Insider Ownership
0.30%
Retail Ownership
89.16%
Institutional Holders
65.00
Celldex Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 13.72% | 0.05% | 8,075,940 | 428,483 | 5.60% | 298,890,539 | Jun 30, 2024 |
| FMR LLC | 13.30% | 0.02% | 7,829,164 | -1,896,877 | -19.50% | 289,757,360 | Jun 30, 2024 |
| BLACKROCK INC. | 7.97% | 0.00% | 4,690,761 | 178,837 | 3.96% | 173,605,065 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.35% | 0.00% | 3,739,039 | 88,457 | 2.42% | 138,381,833 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 5.76% | 9.67% | 3,388,967 | 488,967 | 16.86% | 125,425,669 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 5.65% | 2.11% | 3,327,132 | 208,045 | 6.67% | 123,137,155 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.39% | 0.01% | 3,172,399 | 85,191 | 2.76% | 117,412,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 5.23% | 0.67% | 3,076,783 | 17,291 | 0.57% | 113,871,739 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.05% | 1.79% | 2,971,615 | 175,000 | 6.26% | 109,979,471 | Jun 30, 2024 |
| STATE STREET CORP | 4.52% | 0.00% | 2,659,088 | -320,663 | -10.76% | 98,412,847,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.29% | 0.19% | 1,937,991 | 654,194 | 50.96% | 71,725,058 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.61% | 0.01% | 1,533,956 | 119,578 | 8.45% | 56,783,111 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.42% | 3.60% | 1,425,000 | 558,532 | 64.46% | 52,739,250 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.38% | 1.56% | 1,398,994 | 26,809 | 1.95% | 51,776,768 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.35% | 0.06% | 1,383,680 | -111,275 | -7.44% | 51,209,997 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.34% | 0.07% | 1,377,868 | 479,068 | 53.30% | 50,994,896 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 1.70% | 0.02% | 1,003,085 | 315,005 | 45.78% | 37,124,176 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.48% | 0.01% | 874,193 | 309,390 | 54.78% | 32,353,883 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 1.44% | 1.83% | 850,000 | 850,000 | 100.00% | 31,458,500 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.44% | 0.03% | 845,560 | 272,389 | 47.52% | 31,294,176 | Jun 30, 2024 |
Celldex Therapeutics's largest institutional shareholder is WELLINGTON MANAGEMENT GROUP LLP, holding 13.72% of the company's total share outstanding, currently valued at $298.89M. The top 10 institutional shareholders own together 72.92% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KYNAM CAPITAL MANAGEMENT, LP | 5.76% | 9.67% | 3,388,967 | 488,967 | 16.86% | 125,425,669 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 0.84% | 4.12% | 497,270 | - | - | 18,403,963 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.42% | 3.60% | 1,425,000 | 558,532 | 64.46% | 52,739,250 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.64% | 3.27% | 374,910 | 75,594 | 25.26% | 13,875,419 | Jun 30, 2024 |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 0.42% | 2.89% | 249,220 | - | - | 9,223,635 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 5.65% | 2.11% | 3,327,132 | 208,045 | 6.67% | 123,137,155 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.81% | 2.03% | 475,400 | -34,600 | -6.78% | 17,594,554 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 1.44% | 1.83% | 850,000 | 850,000 | 100.00% | 31,458,500 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.05% | 1.79% | 2,971,615 | 175,000 | 6.26% | 109,979,471 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.22% | 1.61% | 718,723 | -177,731 | -19.83% | 26,599,938 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 1.08% | 1.60% | 633,015 | -78,100 | -10.98% | 23,427,885 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.25% | 1.57% | 144,467 | 144,467 | 100.00% | 5,346,724 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.53% | 1.56% | 309,265 | 32,269 | 11.65% | 11,445,898 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.38% | 1.56% | 1,398,994 | 26,809 | 1.95% | 51,776,768 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.08% | 1.29% | 47,500 | 9,000 | 23.38% | 1,757,975 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.93% | 1.05% | 547,707 | -254,070 | -31.69% | 20,270,636 | Jun 30, 2024 |
| MIRADOR CAPITAL PARTNERS LP | 0.19% | 0.78% | 112,379 | 7,620 | 7.27% | 4,159,147 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.10% | 0.74% | 650,000 | - | - | 24,056,500 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 5.23% | 0.67% | 3,076,783 | 17,291 | 0.57% | 113,871,739 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.13% | 0.54% | 75,300 | 75,300 | 100.00% | 2,786,853 | Jun 30, 2024 |
The largest Celldex Therapeutics shareholder by % of total assets is KYNAM CAPITAL MANAGEMENT, LP. The company owns 3.39M shares of Celldex Therapeutics (CLDX), representing 9.67% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 1.44% | 1.83% | 850,000 | 850,000 | 100.00% | 31,458,500 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.29% | 0.19% | 1,937,991 | 654,194 | 50.96% | 71,725,058 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.42% | 3.60% | 1,425,000 | 558,532 | 64.46% | 52,739,250 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 5.76% | 9.67% | 3,388,967 | 488,967 | 16.86% | 125,425,669 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.34% | 0.07% | 1,377,868 | 479,068 | 53.30% | 50,994,896 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 13.72% | 0.05% | 8,075,940 | 428,483 | 5.60% | 298,890,539 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 1.70% | 0.02% | 1,003,085 | 315,005 | 45.78% | 37,124,176 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.48% | 0.01% | 874,193 | 309,390 | 54.78% | 32,353,883 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.44% | 0.03% | 845,560 | 272,389 | 47.52% | 31,294,176 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.71% | 0.01% | 416,000 | 233,928 | 128.48% | 15,396,196 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 5.65% | 2.11% | 3,327,132 | 208,045 | 6.67% | 123,137,155 | Jun 30, 2024 |
| BLACKROCK INC. | 7.97% | 0.00% | 4,690,761 | 178,837 | 3.96% | 173,605,065 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.05% | 1.79% | 2,971,615 | 175,000 | 6.26% | 109,979,471 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.25% | 1.57% | 144,467 | 144,467 | 100.00% | 5,346,724 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.20% | 0.03% | 119,629 | 119,629 | 100.00% | 4,427,469 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.61% | 0.01% | 1,533,956 | 119,578 | 8.45% | 56,783,111 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.20% | 0.02% | 118,347 | 118,347 | 100.00% | 4,380,022 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.35% | 0.00% | 3,739,039 | 88,457 | 2.42% | 138,381,833 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.39% | 0.01% | 3,172,399 | 85,191 | 2.76% | 117,412,000 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.64% | 3.27% | 374,910 | 75,594 | 25.26% | 13,875,419 | Jun 30, 2024 |
As of Jun 30 2024, Celldex Therapeutics's largest institutional buyer is NOVO HOLDINGS A/S. The company purchased 850.00K stocks of CLDX, valued at $31.46M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 13.30% | 0.02% | 7,829,164 | -1,896,877 | -19.50% | 289,757,360 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -650,000 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 4.52% | 0.00% | 2,659,088 | -320,663 | -10.76% | 98,412,847,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.07% | 0.00% | 42,788 | -269,682 | -86.31% | 1,583,584 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.93% | 1.05% | 547,707 | -254,070 | -31.69% | 20,270,636 | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -253,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.28% | 0.00% | 163,992 | -212,129 | -56.40% | 6,069,365 | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.22% | 1.61% | 718,723 | -177,731 | -19.83% | 26,599,938 | Jun 30, 2024 |
| INVESCO LTD. | 0.07% | 0.00% | 41,133 | -173,215 | -80.81% | 1,522,332 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.07% | 0.00% | 43,750 | -164,501 | -78.99% | 1,619,188 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.04% | 0.00% | 23,428 | -155,001 | -86.87% | 867,070 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -151,391 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | 0.00% | 647 | -120,926 | -99.47% | 23,945 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.35% | 0.06% | 1,383,680 | -111,275 | -7.44% | 51,209,997 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -109,000 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.27% | 0.00% | 160,596 | -95,752 | -37.35% | 5,943,658 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -87,500 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.21% | 0.01% | 125,506 | -80,658 | -39.12% | 4,644,977 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Celldex Therapeutics's biggest institutional seller is FMR LLC. The company sold -1.90M shares of CLDX, valued at $289.76M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 1.44% | 1.83% | 850,000 | 850,000 | 100.00% | 31,458,500 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.25% | 1.57% | 144,467 | 144,467 | 100.00% | 5,346,724 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.20% | 0.02% | 118,347 | 118,347 | 100.00% | 4,380,022 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.13% | 0.54% | 75,300 | 75,300 | 100.00% | 2,786,853 | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.08% | 0.00% | 44,445 | 44,445 | 100.00% | 1,644,909 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.06% | 0.01% | 38,150 | 38,150 | 100.00% | 1,412,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.00% | 35,412 | 35,412 | 100.00% | 1,313,657 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.01% | 34,752 | 34,752 | 100.00% | 1,286,172 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.05% | 0.06% | 27,392 | 27,392 | 100.00% | 1,013,778 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.03% | 0.02% | 20,300 | 20,300 | 100.00% | 751,303 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 10,945 | 10,945 | 100.00% | 405,074 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.02% | 0.13% | 9,627 | 9,627 | 100.00% | 356,295 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.01% | 0.12% | 6,179 | 6,179 | 100.00% | 228,685 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.00% | 0.02% | 2,053 | 2,053 | 100.00% | 75,997 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 303 | 303 | 100.00% | 11,214 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 139 | 139 | 100.00% | 5,145 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 33 | 33 | 100.00% | 1,221 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 28 | 28 | 100.00% | 1,055 | Jun 30, 2024 |
| J.SAFRA ASSET MANAGEMENT CORP | - | 0.00% | 25 | 25 | 100.00% | 925 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 17 | 17 | 100.00% | 629 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | - | - | 3 | 3 | 100.00% | 126 | Jun 30, 2024 |
| ASSETMARK, INC | - | - | 1 | 1 | 100.00% | 37 | Jun 30, 2024 |
Celldex Therapeutics's largest new institutional shareholder by number of shares is NOVO HOLDINGS A/S, purchased 850.00K shares, valued at $31.46M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -650,000 | -100.00% | - | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -253,000 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -151,391 | -100.00% | - | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -109,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -87,500 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -71,100 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -70,115 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -67,434 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -67,384 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -64,769 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -49,457 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -43,431 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -33,586 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -30,629 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -25,779 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -20,200 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -19,644 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -19,166 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -19,065 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -16,300 | -100.00% | - | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | - | - | - | -14,687 | -100.00% | - | Jun 30, 2024 |
| CONCENTRIC CAPITAL STRATEGIES, LP | - | - | - | -11,710 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -11,200 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -8,453 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -8,158 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -5,534 | -100.00% | - | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -4,824 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -4,100 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,269 | -100.00% | - | Jun 30, 2024 |
| POINT72 HONG KONG LTD | - | - | - | -2,559 | -100.00% | - | Jun 30, 2024 |
| WESTEND CAPITAL MANAGEMENT, LLC | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -19 | -100.00% | - | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Celldex Therapeutics's largest sold out institutional shareholder by shares sold is LOGOS GLOBAL MANAGEMENT LP, sold -0.65M shares, valued at -, as of undefined.
Celldex Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 2.52% | 17,865 | - | - | Dec 31, 2023 |
| ALGER FUNDS II | 0.86% | 195,498 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.41% | 100,331 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.41% | 1,352,507 | 1,054,891 | 354.45% | Mar 31, 2024 |
| Tema ETF Trust | 0.26% | 11,735 | 175 | 1.51% | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.15% | 730,785 | 730,785 | - | Mar 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.12% | 31,247 | - | - | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.12% | 44,919 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.11% | 963,652 | -907,648 | -48.50% | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.11% | 1,303,005 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.09% | 87,919 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.09% | 277,126 | 277,126 | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 33,552 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.06% | 128,848 | 113,032 | 714.67% | Feb 29, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.04% | 26,214 | - | - | Feb 29, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.04% | 2,219,651 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 62,757 | 48,993 | 355.95% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 95,000 | -5,000 | -5.00% | Mar 31, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.03% | 115,955 | -362,911 | -75.79% | Mar 28, 2024 |
| FIDELITY CAPITAL TRUST | 0.03% | 279,500 | 137,400 | 96.69% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 50,200 | - | - | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,273,600 | -333,600 | -20.76% | Feb 29, 2024 |
| Humankind Benefit Corp | 0.02% | 420 | 17 | 4.22% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.02% | 147,700 | 3,300 | 2.29% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,667,503 | 476,000 | 39.95% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 69,555 | 58,333 | 519.81% | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.02% | 1,178,600 | 1,178,600 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 108,930 | 24,719 | 29.35% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,188 | 2,112 | 29.85% | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.01% | 145,510 | -585 | -0.40% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 88,485 | 84,080 | 1908.74% | Mar 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 25,500 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 2,975,782 | -351,981 | -10.58% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 18,826 | 279 | 1.50% | Feb 29, 2024 |
| Tekla World Healthcare Fund | 0.01% | 7,053 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,296 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.01% | 1,064,777 | 28,377 | 2.74% | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 193,710 | 102,841 | 113.18% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 36,683 | - | - | Mar 28, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 175,000 | -15,000 | -7.89% | Mar 31, 2024 |
| FORUM FUNDS II | 0.00% | 3,251 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 40,699 | 7,320 | 21.93% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 131,255 | 3,610 | 2.83% | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 14,700 | 14,700 | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 234,403 | 225,106 | 2421.28% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 512,676 | 17,236 | 3.48% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,198 | 1,582 | 34.27% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 46,000 | -4,000 | -8.00% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,336 | 4,559 | 586.74% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,270 | -361 | -13.72% | Jan 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 13,255 | 8,918 | 205.63% | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 40,070 | 4,535 | 12.76% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 23,056 | 5,082 | 28.27% | Mar 31, 2024 |
| KINETICS PORTFOLIOS TRUST | 0.00% | 1,752 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 9,310 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 142,110 | 12,702 | 9.82% | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 1,978 | -2,842 | -58.96% | Feb 29, 2024 |
| ProFunds | 0.00% | 10,200 | 1,512 | 17.40% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 90,469 | 3,190 | 3.65% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 3,199 | 2,174 | 212.10% | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 3,152,201 | -476,612 | -13.13% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 167,744 | 1,829 | 1.10% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 19,630 | 1,049 | 5.65% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,958 | 674 | 29.51% | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,286 | -171 | -6.96% | Mar 28, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 3,305 | - | - | Aug 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 286,326 | 9,864 | 3.57% | Feb 29, 2024 |
| Global X Funds | 0.00% | 21,218 | 1,222 | 6.11% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,733 | -471 | -7.59% | Mar 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 13,660 | - | - | Feb 29, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 55,910 | -4,218 | -7.02% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 22,500 | 4,400 | 24.31% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 5,964 | 2,659 | 80.45% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 32,595 | 4,459 | 15.85% | Mar 28, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 269,739 | 75,760 | 39.06% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 87,812 | -240 | -0.27% | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 24,557 | -51,775 | -67.83% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 760 | - | - | Mar 28, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,069 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 172,663 | 40,726 | 30.87% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,343 | 1,343 | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 2,181,796 | 429,184 | 24.49% | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 6,670 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 15,558 | 1,454 | 10.31% | Mar 31, 2024 |
| GPS Funds I | 0.00% | 613 | - | - | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 1,726 | 175 | 11.28% | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 1,452 | - | - | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 21,323 | -86,887 | -80.29% | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 206,387 | 22,704 | 12.36% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 423 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,907 | 7,579 | 570.71% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,012 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 539 | - | - | Feb 29, 2024 |
| Trust for Advised Portfolios | 0.00% | 1,674 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 2,000 | 400 | 25.00% | Mar 28, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 31,487 | 5,499 | 21.16% | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 56,328 | 34,177 | 154.29% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 64,100 | -17,092 | -21.05% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 17,830 | -72 | -0.40% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,908 | -281 | -3.91% | Jan 31, 2024 |
Celldex Therapeutics's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 17.86K shares, compromising 2.52% of its total assets.
Celldex Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 65 | -67.98% |
| 31 Mar, 24 | 203 | 15.34% |
| 31 Dec, 23 | 176 | 12.10% |
| 30 Sep, 23 | 157 | -1.88% |
| 30 Jun, 23 | 160 | -4.76% |
| 31 Mar, 23 | 168 | -7.18% |
| 31 Dec, 22 | 181 | 13.13% |
| 30 Sep, 22 | 160 | -11.60% |
| 30 Jun, 22 | 181 | -0.55% |
| 31 Mar, 22 | 182 | -4.71% |
| 31 Dec, 21 | 191 | 7.91% |
| 30 Sep, 21 | 177 | 25.53% |
| 30 Jun, 21 | 141 | 13.71% |
| 31 Mar, 21 | 124 | -5.34% |
| 31 Dec, 20 | 131 | 40.86% |
| 30 Sep, 20 | 93 | 22.37% |
| 30 Jun, 20 | 76 | 111.11% |
| 31 Mar, 20 | 36 | -12.20% |
| 31 Dec, 19 | 41 | -12.77% |
| 30 Sep, 19 | 47 | -2.08% |
| 30 Jun, 19 | 48 | 4.35% |
| 31 Mar, 19 | 46 | 4500.00% |
| 31 Dec, 18 | 1 | - |
As of 30 Jun 24, 65 institutions are holding Celldex Therapeutics's shares, representing a decrease of -67.98% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,206,849 | -91.04% |
| 31 Mar, 24 | 69,304,097 | 13.64% |
| 31 Dec, 23 | 60,983,211 | 20.59% |
| 30 Sep, 23 | 50,571,217 | 0.41% |
| 30 Jun, 23 | 50,367,149 | 1.75% |
| 31 Mar, 23 | 49,502,173 | 1.73% |
| 31 Dec, 22 | 48,658,486 | -1.34% |
| 30 Sep, 22 | 49,320,509 | 2.28% |
| 30 Jun, 22 | 48,222,998 | -2.88% |
| 31 Mar, 22 | 49,652,359 | 7.15% |
| 31 Dec, 21 | 46,337,389 | 7.11% |
| 30 Sep, 21 | 43,262,739 | 21.48% |
| 30 Jun, 21 | 35,612,944 | 2.74% |
| 31 Mar, 21 | 34,663,132 | -5.85% |
| 31 Dec, 20 | 36,815,130 | 14.49% |
| 30 Sep, 20 | 32,155,836 | 15.73% |
| 30 Jun, 20 | 27,785,564 | 601.37% |
| 31 Mar, 20 | 3,961,589 | 0.95% |
| 31 Dec, 19 | 3,924,185 | 5.78% |
| 30 Sep, 19 | 3,709,586 | 7.00% |
| 30 Jun, 19 | 3,466,768 | 33.15% |
| 31 Mar, 19 | 2,603,631 | 2494.37% |
| 31 Dec, 18 | 100,357 | - |
Celldex Therapeutics (CLDX) has 6.21M shares outstanding as of 30 Jun 24, down -91.04% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.54% | 0.08% |
| 31 Mar, 24 | 117.72% | 0.86% |
| 31 Dec, 23 | 117.21% | 1.02% |
| 30 Sep, 23 | 107.00% | 0.94% |
| 30 Jun, 23 | 106.59% | 0.97% |
| 31 Mar, 23 | 104.85% | 0.98% |
| 31 Dec, 22 | 103.24% | 0.93% |
| 30 Sep, 22 | 105.13% | 0.99% |
| 30 Jun, 22 | 103.13% | 0.91% |
| 31 Mar, 22 | 106.23% | 0.91% |
| 31 Dec, 21 | 108.09% | 1.19% |
| 30 Sep, 21 | 95.19% | 1.16% |
| 30 Jun, 21 | 90.54% | 1.17% |
| 31 Mar, 21 | 88.03% | 1.02% |
| 31 Dec, 20 | 93.02% | 1.39% |
| 30 Sep, 20 | 81.87% | 0.52% |
| 30 Jun, 20 | 125.83% | 24.29% |
| 31 Mar, 20 | 22.76% | 3.11% |
| 31 Dec, 19 | 27.05% | 4.59% |
| 30 Sep, 19 | 24.27% | 3.93% |
| 30 Jun, 19 | 24.85% | 5.54% |
| 31 Mar, 19 | 21.17% | 639862.09% |
| 31 Dec, 18 | 0.06% | - |
As of 30 Jun 24, Celldex Therapeutics is held by 10.54% institutional shareholders, representing a 0.08% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -73.44% |
| 31 Mar, 24 | 128 | 40.66% |
| 31 Dec, 23 | 91 | 15.19% |
| 30 Sep, 23 | 79 | 1.28% |
| 30 Jun, 23 | 78 | 2.63% |
| 31 Mar, 23 | 76 | -8.43% |
| 31 Dec, 22 | 83 | 5.06% |
| 30 Sep, 22 | 79 | 8.22% |
| 30 Jun, 22 | 73 | -14.12% |
| 31 Mar, 22 | 85 | -11.46% |
| 31 Dec, 21 | 96 | -2.04% |
| 30 Sep, 21 | 98 | 28.95% |
| 30 Jun, 21 | 76 | 20.63% |
| 31 Mar, 21 | 63 | -22.22% |
| 31 Dec, 20 | 81 | 26.56% |
| 30 Sep, 20 | 64 | 23.08% |
| 30 Jun, 20 | 52 | 300.00% |
| 31 Mar, 20 | 13 | -7.14% |
| 31 Dec, 19 | 14 | -22.22% |
| 30 Sep, 19 | 18 | -25.00% |
| 30 Jun, 19 | 24 | -44.19% |
| 31 Mar, 19 | 43 | 4200.00% |
| 31 Dec, 18 | 1 | - |
34 institutional shareholders have increased their position in CLDX stock as of 30 Jun 24 compared to 128 in the previous quarter (a -73.44% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 13 | -69.77% |
| 31 Mar, 24 | 43 | -10.42% |
| 31 Dec, 23 | 48 | 14.29% |
| 30 Sep, 23 | 42 | -8.70% |
| 30 Jun, 23 | 46 | -14.81% |
| 31 Mar, 23 | 54 | -5.26% |
| 31 Dec, 22 | 57 | 39.02% |
| 30 Sep, 22 | 41 | -18.00% |
| 30 Jun, 22 | 50 | - |
| 31 Mar, 22 | 50 | -3.85% |
| 31 Dec, 21 | 52 | 8.33% |
| 30 Sep, 21 | 48 | 33.33% |
| 30 Jun, 21 | 36 | 2.86% |
| 31 Mar, 21 | 35 | 34.62% |
| 31 Dec, 20 | 26 | 116.67% |
| 30 Sep, 20 | 12 | 50.00% |
| 30 Jun, 20 | 8 | -11.11% |
| 31 Mar, 20 | 9 | -25.00% |
| 31 Dec, 19 | 12 | -20.00% |
| 30 Sep, 19 | 15 | 36.36% |
| 30 Jun, 19 | 11 | 1000.00% |
| 31 Mar, 19 | 1 | - |
| 31 Dec, 18 | - | - |
13 institutional shareholders have reduced their position in CLDX stock as of 30 Jun 24 compared to 43 in the previous quarter (a -69.77% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 65 | -67.98% | 6,206,849 | -91.04% | 10.54% | 0.08% | 34 | -73.44% | 13 | -69.77% |
| 31 Mar, 24 | 203 | 15.34% | 69,304,097 | 13.64% | 117.72% | 0.86% | 128 | 40.66% | 43 | -10.42% |
| 31 Dec, 23 | 176 | 12.10% | 60,983,211 | 20.59% | 117.21% | 1.02% | 91 | 15.19% | 48 | 14.29% |
| 30 Sep, 23 | 157 | -1.88% | 50,571,217 | 0.41% | 107.00% | 0.94% | 79 | 1.28% | 42 | -8.70% |
| 30 Jun, 23 | 160 | -4.76% | 50,367,149 | 1.75% | 106.59% | 0.97% | 78 | 2.63% | 46 | -14.81% |
| 31 Mar, 23 | 168 | -7.18% | 49,502,173 | 1.73% | 104.85% | 0.98% | 76 | -8.43% | 54 | -5.26% |
| 31 Dec, 22 | 181 | 13.13% | 48,658,486 | -1.34% | 103.24% | 0.93% | 83 | 5.06% | 57 | 39.02% |
| 30 Sep, 22 | 160 | -11.60% | 49,320,509 | 2.28% | 105.13% | 0.99% | 79 | 8.22% | 41 | -18.00% |
| 30 Jun, 22 | 181 | -0.55% | 48,222,998 | -2.88% | 103.13% | 0.91% | 73 | -14.12% | 50 | - |
| 31 Mar, 22 | 182 | -4.71% | 49,652,359 | 7.15% | 106.23% | 0.91% | 85 | -11.46% | 50 | -3.85% |
| 31 Dec, 21 | 191 | 7.91% | 46,337,389 | 7.11% | 108.09% | 1.19% | 96 | -2.04% | 52 | 8.33% |
| 30 Sep, 21 | 177 | 25.53% | 43,262,739 | 21.48% | 95.19% | 1.16% | 98 | 28.95% | 48 | 33.33% |
| 30 Jun, 21 | 141 | 13.71% | 35,612,944 | 2.74% | 90.54% | 1.17% | 76 | 20.63% | 36 | 2.86% |
| 31 Mar, 21 | 124 | -5.34% | 34,663,132 | -5.85% | 88.03% | 1.02% | 63 | -22.22% | 35 | 34.62% |
| 31 Dec, 20 | 131 | 40.86% | 36,815,130 | 14.49% | 93.02% | 1.39% | 81 | 26.56% | 26 | 116.67% |
| 30 Sep, 20 | 93 | 22.37% | 32,155,836 | 15.73% | 81.87% | 0.52% | 64 | 23.08% | 12 | 50.00% |
| 30 Jun, 20 | 76 | 111.11% | 27,785,564 | 601.37% | 125.83% | 24.29% | 52 | 300.00% | 8 | -11.11% |
| 31 Mar, 20 | 36 | -12.20% | 3,961,589 | 0.95% | 22.76% | 3.11% | 13 | -7.14% | 9 | -25.00% |
| 31 Dec, 19 | 41 | -12.77% | 3,924,185 | 5.78% | 27.05% | 4.59% | 14 | -22.22% | 12 | -20.00% |
| 30 Sep, 19 | 47 | -2.08% | 3,709,586 | 7.00% | 24.27% | 3.93% | 18 | -25.00% | 15 | 36.36% |
| 30 Jun, 19 | 48 | 4.35% | 3,466,768 | 33.15% | 24.85% | 5.54% | 24 | -44.19% | 11 | 1000.00% |
| 31 Mar, 19 | 46 | 4500.00% | 2,603,631 | 2494.37% | 21.17% | 639862.09% | 43 | 4200.00% | 1 | - |
| 31 Dec, 18 | 1 | - | 100,357 | - | 0.06% | - | 1 | - | - | - |
Celldex Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Celldex Therapeutics's stock was made by Martin Samuel Bates on Jun 18 2024, selling 16,968 shares at $10.38 per share (valued at $176.13K).
Celldex Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 18 | 28 | 64.29% |
| Q1 2024 | 3 | 3 | 100.00% |
| Q2 2023 | 17 | - | - |
| Q1 2023 | 1 | - | - |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 7 | 18 | 38.89% |
| Q2 2022 | 28 | - | - |
| Q4 2021 | 13 | 27 | 48.15% |
| Q3 2021 | 5 | 6 | 83.33% |
| Q2 2021 | 15 | - | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | 2 | 3 | 66.67% |
| Q2 2020 | 21 | - | - |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 13 | - | - |
| Q4 2018 | - | 3 | - |
| Q3 2018 | 1 | 3 | 33.33% |
| Q2 2018 | 16 | 3 | 533.33% |
| Q1 2018 | - | 3 | - |
| Q4 2017 | 1 | 3 | 33.33% |
18 total buy trades, and 28 total sell trades (buy/sell ratio of 0.64%) were made by Celldex Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 10 | - |
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 8 | - |
| Q2 2022 | - | - | - |
| Q4 2021 | - | 14 | - |
| Q3 2021 | 1 | 2 | 50.00% |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q2 2020 | 7 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 1 | - | - |
| Q2 2018 | 1 | - | - |
| Q1 2018 | - | - | - |
| Q4 2017 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 10 open market sell trades of Celldex Therapeutics's stocks.
Celldex Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| DICE | DICE Therapeutics, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| BCAB | BioAtla, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| MGTX | MeiraGTx Holdings plc |
| VTYX | Ventyx Biosciences, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| RNA | Avidity Biosciences, Inc. |
| IMTX | Immatics N.V. |
| TVTX | Travere Therapeutics, Inc. |
| COGT | Cogent Biosciences, Inc. |
| ALXO | ALX Oncology Holdings Inc. |
| KROS | Keros Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| SWTX | SpringWorks Therapeutics, Inc. |
| CYTK | Cytokinetics, Incorporated |
| KRTX | Karuna Therapeutics, Inc. |
| FIXX | Q32 Bio Inc. |
CLDX Ownership FAQ
Who Owns Celldex Therapeutics?
Celldex Therapeutics is owned by institutional shareholders (10.54%), insiders (0.30%), and public (89.16%). The largest institutional shareholder of Celldex Therapeutics is WELLINGTON MANAGEMENT GROUP LLP (13.72% of total shares) and the top mutual fund owner is Alger ETF Trust (2.52% of total shares).
Who are the major institutional shareholders of Celldex Therapeutics?
Celldex Therapeutics's major institutional shareholders are WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, BLACKROCK INC., VANGUARD GROUP INC, and KYNAM CAPITAL MANAGEMENT, LP. The top five shareholders own together 47.09% of the company's share outstanding.
How many Celldex Therapeutics shareholders are there?
As of Jun 2024, there are 65 institutional shareholders of Celldex Therapeutics.
What percentage of Celldex Therapeutics is owned by WELLINGTON MANAGEMENT GROUP LLP?
WELLINGTON MANAGEMENT GROUP LLP owns 8.08M shares of Celldex Therapeutics, representing 13.72% of the company's total shares outstanding, valued at $298.89M (as of Jun 2024).
What percentage of Celldex Therapeutics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 7.83M shares of Celldex Therapeutics (CLDX), compromising 13.30% of the company, valued at $289.76M.
What percentage of Celldex Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Celldex Therapeutics. The company owns 4.69M of the company's shares outstanding (worth $173.61M).